Jon P. Stonehouse is currently President and Chief Executive Officer of BioCryst Pharmaceuticals, Inc., and has over 20 years of pharmaceutical executive experience. Prior to joining BioCryst in 2007, he served as Senior Vice President of Corporate Development at Merck KGaA. Among his accomplishments, he was responsible for leading the effort to develop a strategy for Merck that significantly changed the company, culminating in the 2007 acquisition of Serono, S.A., the largest biotechnology company in Europe at that time. Mr. Stonehouse received a B.S. in Microbiology from the University of Minnesota-Twin Cities.